Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Jaxsta’s symphony struggles to find its rhythm, employs third CEO in two years
    • News

    Jaxsta’s symphony struggles to find its rhythm, employs third CEO in two years

    In what can be considered a rather intense game of musical chairs, music credits database company Jaxsta (ASX: JXT) has appointed its third CEO in less than two years—Josh Simons. Simons replaces Beth Appleton who was appointed to the role in April 2022. Now the former CEO, Appleton, commented, “I will relish my time at

    Read More
    Public
  • Australian market to open flat after yesterday’s optimism
    • Market Update

    Australian market to open flat after yesterday’s optimism

    The XJO is expected to edge lower on open this morning following a similar move from the U.S last night. Their futures have moved into the green, which should help our market hold the strong gains from yesterday. CPI came in much lower than expected yesterday, and there was a collective sigh of relief from

    Read More
    Public
  • Invex struggles to recruit patients, witnesses test failures for its clinical trial for intracranial hypertension alleviating drug
    • News

    Invex struggles to recruit patients, witnesses test failures for its clinical trial for intracranial hypertension alleviating drug

    The pressure is on for biotech company Invex Therapeutics (ASX: IXC), which is not only struggling to recruit patients but is also dealing with underwhelming results for its flagship drug Presendin, tackling idiopathic intracranial hypertension (IIH). The Company has initiated a comprehensive assessment of its Phase IIH EVOLVE program, which explores the potential of Presendin

    Read More
    Public
  • Kip McGrath expects FY23 revenue to see 10% boost as education operators profit from increased subsidies
    • News

    Kip McGrath expects FY23 revenue to see 10% boost as education operators profit from increased subsidies

    Despite all the corporate cash grabs to profit from the Government’s Child Care Subsidy boost, there’s plenty of profit opportunity in the next age bracket up too with tutoring provider Kip McGrath (ASX: KME) issuing an earnings upgrade, primarily from rising demand for tuition services. Government-affiliated tutoring provider Kip McGrath forecasts a revenue boost, citing

    Read More
    Public
  • US markets jump, Australians nervous ahead of CPI read
    • Market Update

    US markets jump, Australians nervous ahead of CPI read

    The XJO is expected to edge higher on open following a decent recovery from the U.S last night and their flat futures this morning. Yesterday we managed to hold gains as we rebounded from the bottom of the range at roughly 7,100. For a moment there it looked like we were going to break lower,

    Read More
    Public
  • XRF Scientific launches xrTGA, a weight-temperature measuring device
    • News

    XRF Scientific launches xrTGA, a weight-temperature measuring device

    After an extensive product development process, lab instrument manufacturing company XRF Scientific (ASX: XRF) has launched a new product—xrTGA. xrTGA is a thermogravimetric analyser (TGA), an instrument which measures the weight of an object over time while heating it to different temperature points. The instrument comprises a sample-heating furnace and a precise weighing scale for

    Read More
    Public
  • «
  • ‹
  • 223
  • 224
  • 225
  • 226
  • 227
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.